{"?xml":{"@version":"1.0"},"edm:RDF":{"@xmlns:dc":"http://purl.org/dc/elements/1.1/","@xmlns:edm":"http://www.europeana.eu/schemas/edm/","@xmlns:wgs84_pos":"http://www.w3.org/2003/01/geo/wgs84_pos","@xmlns:foaf":"http://xmlns.com/foaf/0.1/","@xmlns:rdaGr2":"http://rdvocab.info/ElementsGr2","@xmlns:oai":"http://www.openarchives.org/OAI/2.0/","@xmlns:owl":"http://www.w3.org/2002/07/owl#","@xmlns:rdf":"http://www.w3.org/1999/02/22-rdf-syntax-ns#","@xmlns:ore":"http://www.openarchives.org/ore/terms/","@xmlns:skos":"http://www.w3.org/2004/02/skos/core#","@xmlns:dcterms":"http://purl.org/dc/terms/","edm:WebResource":[{"@rdf:about":"http://www.dlib.si/stream/URN:NBN:SI:doc-AIXF7VST/0b50132b-3ffd-45bc-bb09-ba615b99540e/PDF","dcterms:extent":"731 KB"},{"@rdf:about":"http://www.dlib.si/stream/URN:NBN:SI:doc-AIXF7VST/a96d7ac1-e695-447c-8eb0-36af87e18140/TEXT","dcterms:extent":"0 KB"}],"edm:TimeSpan":{"@rdf:about":"2005-2025","edm:begin":{"@xml:lang":"en","#text":"2005"},"edm:end":{"@xml:lang":"en","#text":"2025"}},"edm:ProvidedCHO":{"@rdf:about":"URN:NBN:SI:doc-AIXF7VST","dcterms:isPartOf":[{"@rdf:resource":"https://www.dlib.si/details/URN:NBN:SI:spr-8ER5ZBJN"},{"@xml:lang":"sl","#text":"Farmacevtski vestnik"}],"dcterms:issued":"2024","dc:creator":"Kodrič, Ana","dc:format":[{"@xml:lang":"sl","#text":"številka:1"},{"@xml:lang":"sl","#text":"letnik:75"},{"@xml:lang":"sl","#text":"str. 3-12"}],"dc:identifier":["ISSN:0014-8229","COBISSID_HOST:191375363","URN:URN:NBN:SI:doc-AIXF7VST"],"dc:language":"sl","dc:publisher":{"@xml:lang":"sl","#text":"Slovensko farmacevtsko društvo"},"dc:subject":[{"@xml:lang":"en","#text":"essential oil"},{"@xml:lang":"sl","#text":"Farmacevti"},{"@xml:lang":"en","#text":"lavander"},{"@xml:lang":"en","#text":"Lavandula angustifolia"},{"@xml:lang":"en","#text":"Lavandula x intermedia"},{"@xml:lang":"sl","#text":"sodelovanje pri zdravljenju z zdravili"},{"@xml:lang":"sl","#text":"spletna anketa"},{"@xml:lang":"sl","#text":"Zdravljenje"},{"@xml:lang":"sl","#text":"Zdravniki"}],"dcterms:temporal":{"@rdf:resource":"2005-2025"},"dc:title":{"@xml:lang":"sl","#text":"Obravnava sodelovanja pacientov pri zdravljenju z zdravili s strani zdravnikov in farmacevtov v Sloveniji| Medication adherence management in physician's and pharmacist's practices in Slovenia|"},"dc:description":[{"@xml:lang":"sl","#text":"Ensuring medication adherence depends largely on healthcare professionals' roles. This article presents the Slovenian findings from an international cross-sectional survey examining current practices and unmet needs in medication adherence among healthcare practitioners. We administered an online survey to community pharmacists, clinical pharmacists and family physicians. Of 178 respondents, 21% were physicians and 79% were pharmacists. Physicians routinely monitor medication adherence in their practice, while only a quarter of pharmacists do so regularly. This is mainly due to time constraints, a lack of adherence assessment methods and the perception that it falls outside routine practice. Nonadherence is primarily addressed through counselling and motivation by both physicians and pharmacists, with a central challenge being patient awareness of medication adherence's importance. Healthcare practitioners acknowledge the critical need for a patient-centric approach and increased education on medication adherence"},{"@xml:lang":"sl","#text":"Zagotavljanje ustreznega sodelovanja pacientov pri zdravljenju z zdravili je v veliki meri odvisno od aktivnosti zdravstvenih delavcev. V članku predstavljamo slovenske rezultate mednarodne presečne raziskave, katere namen je bil raziskati trenutno prakso in nezadovoljene potrebe, vezane na sodelovanje pri zdravljenju z zdravili med zdravstvenimi delavci. Raziskava je potekala v obliki spletne ankete, naslovljene na lekarniške in klinične farmacevte ter zdravnike družinske medicine. Med 178 anketiranci je bilo 21 % zdravnikov in 79 % farmacevtov. Zdravniki v praksi redno spremljajo sodelovanje pri zdravljenju kroničnih bolezni z zdravili, medtem ko to redno počne dobra četrtina farmacevtov. Glavni razlogi za to so pomanjkanje časa ter metod za vrednotenje sodelovanja pri zdravljenju z zdravili in pa mnenje, da to ni del običajne prakse. Nesodelovanje pacientov pri zdravljenju tako zdravniki kot farmacevti najpogosteje naslavljajo s svetovanjem in motiviranjem, kot ključen izziv pa navajajo slabo ozaveščenost med pacienti glede pomena sodelovanja. Pri tem se zavedajo pomembnosti ustreznega pristopa k pacientu in potrebe po izobraževanju na področju sodelovanja pri zdravljenju z zdravili"}],"edm:type":"TEXT","dc:type":[{"@xml:lang":"sl","#text":"znanstveno časopisje"},{"@xml:lang":"en","#text":"journals"},{"@rdf:resource":"http://www.wikidata.org/entity/Q361785"}]},"ore:Aggregation":{"@rdf:about":"http://www.dlib.si/?URN=URN:NBN:SI:doc-AIXF7VST","edm:aggregatedCHO":{"@rdf:resource":"URN:NBN:SI:doc-AIXF7VST"},"edm:isShownBy":{"@rdf:resource":"http://www.dlib.si/stream/URN:NBN:SI:doc-AIXF7VST/0b50132b-3ffd-45bc-bb09-ba615b99540e/PDF"},"edm:rights":{"@rdf:resource":"http://rightsstatements.org/vocab/InC/1.0/"},"edm:provider":"Slovenian National E-content Aggregator","edm:intermediateProvider":{"@xml:lang":"en","#text":"National and University Library of Slovenia"},"edm:dataProvider":{"@xml:lang":"sl","#text":"Slovensko farmacevtsko društvo"},"edm:object":{"@rdf:resource":"http://www.dlib.si/streamdb/URN:NBN:SI:doc-AIXF7VST/maxi/edm"},"edm:isShownAt":{"@rdf:resource":"http://www.dlib.si/details/URN:NBN:SI:doc-AIXF7VST"}}}}